Home > News > Seven Maryland startups get TEDCO funding
April 3rd, 2009
Seven Maryland startups get TEDCO funding
Abstract:
The Maryland Technology Development Corporation (TEDCO) says seven Maryland technology companies have received $512,637 total in funding.
Chesapeake Micro Products, LLC; Fyodor Biotechnologies, Inc.; Green Eyes, LLC; Rafagen, Inc.; SD Nanosciences, Inc.; Tendyne Medical, Inc.; and Vorbeck Materials Corporation, each received approximately $75,000 from TEDCO's Maryland Technology Transfer Fund (MTTF).
SD Nanosciences, Inc., located in Beltsville, Md., is working with the University of Maryland College Park to further develop patent-pending carbohydrate-functionalized nanomaterials.
Their vesicle technology, Targeted Delivery Vesicles, encapsulates and target drugs and can be stored and shipped as a stable liquid at room temperature.
SD Nanosciences also has demonstrated their TRIAD technology which uses gold nanoparticle presenting carbohydrates capable of eliciting a potent IgG response directed against polysaccharide and generate a maximal antibody response.
Source:
techjournalsouth.com
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Govt.-Legislation/Regulation/Funding/Policy
Quantum computer improves AI predictions April 17th, 2026
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Nanobiotechnology
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||